HDFC Securities has an ‘add’ call on Dr Lal Pathlabs with a target price of Rs 2910. The company reported a total income of Rs 621.80 crore for the quarter ending 31-12-2024, marking an 11.59% increase from the same quarter last year. The diagnostic sector’s de-rating and moderate earnings growth influenced the latest valuation estimates.Read More
Shares in Chinese EV giant BYD surged to a record high Tuesday after it unveiled new battery technology it says can charge a vehicle in the same time it takes to fill up a petrol car. Separately, on Tuesday, Chinese EV maker Nio said it had signed a deal with battery giant CATL involving cooperation on a passenger car battery swap network.Read More
Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Nulla vitae elit libero, a pharetra augue. Donec sed odio dui. Etiam porta sem malesuada.